We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIGI icon
901
Selective Insurance
SIGI
$5.66B
$2.91M 0.01%
38,724
-1,539
-4% -$119K
JBHT icon
902
JB Hunt Transport Services
JBHT
$25.7B
$2.9M 0.01%
26,253
+2,204
+9% +$227K
EXAS
903
DELISTED
Exact Sciences
EXAS
$2.9M 0.01%
32,121
+4,108
+15% +$468K
MED icon
904
Medifast
MED
$109M
$2.89M 0.01%
27,904
-3,601
-11% -$387K
CRUS icon
905
Cirrus Logic
CRUS
$6.55B
$2.89M 0.01%
53,943
+8,860
+20% +$453K
ON icon
906
ON Semiconductor
ON
$32.7B
$2.88M 0.01%
150,040
-23,116
-13% -$445K
XPO icon
907
XPO
XPO
$23.8B
$2.86M 0.01%
115,529
+10,129
+10% +$234K
CC icon
908
Chemours
CC
$2.51B
$2.86M 0.01%
191,322
-22,053
-10% -$359K
POWI icon
909
Power Integrations
POWI
$3.44B
$2.85M 0.01%
63,138
+500
+0.8% +$21.7K
CYBR
910
DELISTED
CyberArk
CYBR
$2.85M 0.01%
28,544
+4,569
+19% +$551K
ATR icon
911
AptarGroup
ATR
$8.55B
$2.85M 0.01%
24,024
-1,859
-7% -$225K
R icon
912
Ryder
R
$9.92B
$2.84M 0.01%
54,879
-54,623
-50% -$2.85M
VVV icon
913
Valvoline
VVV
$4.92B
$2.84M 0.01%
128,731
+30,077
+30% +$645K
LN
914
DELISTED
LINE Corporation
LN
$2.83M 0.01%
78,835
+23,857
+43% +$794K
EHC icon
915
Encompass Health
EHC
$11B
$2.83M 0.01%
56,139
+3,388
+6% +$170K
LBRDA icon
916
Liberty Broadband Class A
LBRDA
$4.91B
$2.82M 0.01%
26,960
+2,374
+10% +$245K
NATI
917
DELISTED
National Instruments Corp
NATI
$2.81M 0.01%
66,857
-8,363
-11% -$359K
BEN icon
918
Franklin Resources
BEN
$17.7B
$2.78M 0.01%
96,382
-90,271
-48% -$2.76M
TXNM
919
TXNM Energy Inc
TXNM
$6.41B
$2.76M 0.01%
53,014
-1,688
-3% -$85.2K
EME icon
920
Emcor
EME
$36B
$2.75M 0.01%
31,940
+2,845
+10% +$242K
AMED
921
DELISTED
Amedisys
AMED
$2.75M 0.01%
20,969
-3,423
-14% -$446K
WMK icon
922
Weis Markets
WMK
$1.91B
$2.74M 0.01%
71,826
-916
-1% -$34.8K
AWR icon
923
American States Water
AWR
$3.38B
$2.73M 0.01%
30,362
+535
+2% +$44.9K
BZH icon
924
Beazer Homes USA
BZH
$873M
$2.73M 0.01%
182,950
+73,199
+67% +$882K
SNX icon
925
TD Synnex
SNX
$20.5B
$2.72M 0.01%
48,240
-12,432
-20% -$580K

Similar funds

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.